Axxcess Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $794K | Buy |
|
|||||
|
2025
Q2 | $562K | Buy |
|
|||||
|
2025
Q1 | $351K | Buy |
|
|||||
|
2024
Q4 | $390K | Sell |
|
|||||
|
2024
Q3 | $483K | Buy |
|
|||||
|
2024
Q2 | $537K | Sell |
|
|||||
|
2024
Q1 | $678K | Buy |
|
|||||
|
2023
Q4 | $566K | Buy |
|
|||||
|
2023
Q3 | $353K | Sell |
|
|||||
|
2023
Q2 | $500K | Sell |
|
|||||
|
2023
Q1 | $447K | Buy |
|
|||||
|
2022
Q4 | $379K | Sell |
|
|||||
|
2022
Q3 | $794K | Sell |
|
|||||
|
2022
Q2 | $856K | Buy |
|
|||||
|
2022
Q1 | $811K | Sell |
|
|||||
|
2021
Q4 | $1.21M | Buy |
|